Y. Amada

Effects of 2-[N-(4-Chlorophenyl)-N-methylamino]-4H-pyrido[3.2-e]-1,3-thiazin-4-one (YM928), an Orally Active α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptor Antagonist, in Models of Generalized Epileptic Seizure in Mice and Rats

H. Yamashita, Tokio Yamaguchi, M. Okada, 2004, Journal of Pharmacology and Experimental Therapeutics.

Effect of YM928, a novel AMPA receptor antagonist, on seizures in EL mice and kainate-induced seizures in rats

H. Yamashita, Tokio Yamaguchi, M. Okada, 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

Pharmacokinetics of Mirabegron, a β3-Adrenoceptor Agonist for Treatment of Overactive Bladder, in Healthy Japanese Male Subjects: Results from Single- and Multiple-Dose Studies

M. Katashima, M. van Gelderen, Shin Takusagawa, 2013, Clinical Drug Investigation.

Functional Characterization of YM928, a Novel Noncompetitive α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Antagonist

H. Yamashita, N. Matsumoto, R. Tsutsumi, 2003, Journal of Pharmacology and Experimental Therapeutics.

Functional Characterization of YM928, a Novel Noncompetitive AMPA Receptor Antagonist

N. Matsumoto, R. Tsutsumi, M. Okada, 2003 .